Streetbeat News

MGRX

Mangoceuticals, Inc.

https://www.mangorx.com

Industry

Medical - Healthcare Information Services

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Open

2.51

Mkt cap

5.2M

Volume

38K

High

2.62

P/E Ratio

-0.46

52-wk high

16.80

Low

2.41

Div yield

N/A

52-wk low

2.10

Mangoceuticals, Inc. (NASDAQ:MGRX) has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing. The company's stock maintained a closing bid price of at least $1.00 for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 12:40 pm

Mangoceuticals, Inc. (NASDAQ:MGRX) has announced a strategic review to explore potential mergers, acquisitions, divestitures, and other business combinations to maximize shareholder value. The company is considering a wide range of strategic, operational, and financial alternatives with no set timeline for completion.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:20 pm

Mangoceuticals is facing a lawsuit from Eli Lilly, which claims that Mangoceuticals improperly copied its weight-loss medicines, Zepbound and Mounjaro. Mangoceuticals refutes these claims and plans to defend itself vigorously.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 9:14 pm

The article highlights three oversold stocks in the consumer staples sector: Coty Inc, 22nd Century Group Inc, and Mangoceuticals. These stocks have RSI values indicating they are oversold, presenting potential buying opportunities. Coty Inc announced preliminary Q1 results and reiterated its FY25 outlook, while 22nd Century Group's CEO made a significant share purchase. Mangoceuticals announced a reverse stock split.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 11:18 am

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is relevant for investors tracking trading activities and potential impacts on stock prices.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 12:55 pm

Mangoceuticals shares are experiencing an increase in trading activity following the announcement of a 1-for-15 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 5:06 pm

Mangoceuticals has announced a 1-for-15 reverse stock split effective October 16 to regain compliance with Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 7:37 am

Several consumer staples stocks experienced significant price movements in Friday's pre-market session. Notable gainers include Better Choice Co, Veru, Upexi, Mangoceuticals, Oatly Group, and Webuy Global. On the losing side, DDC Enterprise, Australian Oilseeds Holdings, Innovation Beverage Group, Big Tree Cloud Holdings, Eastside Distilling, and Blue Star Foods saw declines.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:07 pm

In Thursday's after-market session, several consumer staples stocks experienced notable movements. Blue Star Foods (BSFC) saw an 18.2% increase, while Veru (VERU) and Australian Oilseeds Holdings (COOT) also gained. On the downside, Big Tree Cloud Holdings (DSY) and DDC Enterprise (DDC) experienced declines.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 8:31 pm

In Tuesday's after-market session, several consumer staples stocks experienced notable price movements. Australian Oilseeds Holdings (NASDAQ:COOT) led the gainers with a 7.4% increase, while AgriFORCE Growing Systems (NASDAQ:AGRI) saw the largest decline, falling 8.0%. Other gainers included Edible Garden (NASDAQ:EDBL) and Safety Shot (NASDAQ:SHOT), while Innovation Beverage Group (NASDAQ:IBG) and BRC (NYSE:BRCC) were among the losers.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.